AIRS Medical nabs FDA clearance for AI MRI recon software

By staff writers

November 16, 2021 -- South Korean startup AIRS Medical has secured clearance from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-based MRI reconstruction software.

SwiftMR uses deep learning trained with high-quality MRI images to improve low-quality images. AIRS Medical launched SwiftMR in South Korea in July; the software has been used with more than 4,000 patients since then, according to the firm.

The company plans to highlight SwiftMR at the upcoming RSNA meeting, it said.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking